Your session is about to expire
← Back to Search
Cannabinol for Knee Replacement Surgery (COPE Trial)
Phase 2 & 3
Waitlist Available
Led By Amit Atrey, MD
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patient is able to provide informed consent to participation in the study
18 years of age and older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks after total knee replacement
Awards & highlights
COPE Trial Summary
This study is evaluating whether medical cannabis can reduce the amount of opiates needed after knee replacement surgery.
COPE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCOPE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 weeks after total knee replacement
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks after total knee replacement
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Opioid consumption
Secondary outcome measures
Health status and quality of life
Narcotics
Oxford knee score
+3 moreCOPE Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Medical CannabisExperimental Treatment1 Intervention
Drug: Cannabidiol
Group II: PlaceboPlacebo Group1 Intervention
Placebo comparator
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cannabinol
Not yet FDA approved
Find a Location
Who is running the clinical trial?
Unity Health TorontoLead Sponsor
533 Previous Clinical Trials
446,243 Total Patients Enrolled
Amit Atrey, MDPrincipal InvestigatorUnity Health Toronto
3 Previous Clinical Trials
582 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger